Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD

DSpace Repository

Show simple item record

dc.contributor.author Helaiwa, Khaled
dc.contributor.author Szurman, Peter
dc.contributor.author Blanke, Björn Rudolf
dc.date.accessioned 2017-12-18T14:42:57Z
dc.date.available 2017-12-18T14:42:57Z
dc.date.issued 2017
dc.identifier.issn 1471-2415
dc.identifier.uri http://hdl.handle.net/10900/79432
dc.language.iso en de_DE
dc.publisher Biomed Central Ltd de_DE
dc.relation.uri http://dx.doi.org/10.1186/s12886-017-0471-x de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD de_DE
dc.type Artikel de_DE
utue.quellen.id 20170815222223_00736
utue.personen.roh Waizel, Maria
utue.personen.roh Todorova, Margarita G.
utue.personen.roh Masyk, Michael
utue.personen.roh Wolf, Katharina
utue.personen.roh Rickmann, Annekatrin
utue.personen.roh Helaiwa, Khaled
utue.personen.roh Blanke, Bjoern R.
utue.personen.roh Szurman, Peter
dcterms.isPartOf.ZSTitelID Bmc Ophthalmology de_DE
dcterms.isPartOf.ZS-Issue Article 79 de_DE
dcterms.isPartOf.ZS-Volume 17 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record